高级检索
当前位置: 首页 > 详情页

1,6-O, O-diacetylbritannilactones inhibits I kappa B kinase beta-dependent NF-kappa B activation

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Dept Biochem & Mol Biol, Inst Basic Med, Shijiazhuang 050017, Peoples R China [2]Hebei Med Univ, Dept Pharmaceut Chem, Coll Pharm, Shijiazhuang 050017, Peoples R China [3]Hebei Med Univ, Dept Pathol, Hosp 4, Shijiazhuang 050017, Peoples R China
出处:
ISSN:

关键词: Sesquiterpene lactones Anti-inflammatory activity Britannilactone Nuclear factor-kappa B I kappa B kinase RAW264 7 cells

摘要:
To determine the chemical constituents responsible for pharmacological effects of Inula britannica-F,three specific sesquiterpene lactones in Inula britannica were isolated from chloroform extract and identified, including britannilactone (BL), 1-O-acetylbritannilactone (ABLO), and 1,6-O,O-diacetylbritannilactone (ABLOO). Electrophoretic mobility shift assay (EMSA) was performed to detect the nuclear translocation of nuclear factor-kappa B (NF-kappa B) p65. The expressions of I kappa B alpha, pI kappa B alpha, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), I kappa B kinase alpha/beta (IKK alpha/beta) and NF-kappa B kinase (NIK) were detected by Western blot and RT-PCR. We found that acetyl side groups enhanced the inhibitory action of the agents on LPS/IFN-gamma-induced iNOS and COX-2 expression. Their inhibiting activity was positive correlation with the acetyl side group number. The effects of LPS/IFN-gamma were reversed by ABLOO, and BL without acetyl side groups showed only a weak inhibitory action. Further study indicated that ABLOO markedly inhibited the phosphorylation of IKK beta down to based level, but not IKK alpha, corresponding with decreased in I kappa B alpha degradation and phosphorylation induced by LPS/IFN-gamma, resulting in the suppression of NF-kappa B nuclear translocation and activity. These results suggest that the acetyl moieties add to the lipophilicity, and consequently enhance cellular penetration, so that ABLOO possess the most anti-inflammatory effect and may be a potent lead structure for the development of therapeutic and cytokine-suppressing remedies valuable for the treatment of various inflammatory diseases. (C) 2008 Elsevier GmbH. All rights reserved.

基金:

基金编号: 305706614 30670845 C2007000831

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2009]版:
大类 | 4 区 医学
小类 | 3 区 植物科学 4 区 药物化学 4 区 药学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 药物化学 1 区 全科医学与补充医学 1 区 药学 1 区 植物科学
JCR分区:
出版当年[2009]版:
Q2 CHEMISTRY, MEDICINAL Q2 PLANT SCIENCES Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 CHEMISTRY, MEDICINAL Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Q1 PHARMACOLOGY & PHARMACY Q1 PLANT SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Dept Biochem & Mol Biol, Inst Basic Med, Shijiazhuang 050017, Peoples R China [3]Hebei Med Univ, Dept Pathol, Hosp 4, Shijiazhuang 050017, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号